FINWIRES · TerminalLIVE
FINWIRES

$EHC

5 stories mentioning EHCUpdated 2d ago

Every FINWIRES story that references EHC, newest first.

Wire

UBS Adjusts Price Target on Encompass Health to $155 From $150, Maintains Buy Rating

Encompass Health (EHC) has an average rating of buy and mean price target of $146.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $124.99, Change: $+0.17, Percent Change: +0.14%

$EHC
Wire

Update: Encompass Health Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance

(Updates with share moves in eighth paragraph).Encompass Health (EHC) reported Q2 adjusted earnings late Wednesday of $1.55 per diluted share, up from $1.40 a year earlier.Analysts polled by FactSet expected $1.48.Revenue for the three months ended June 30 was $1.60 billion, up from $1.46 billion a year earlier.Analysts expected $1.57 billion.For full-year 2026, the company now expects adjusted EPS of $6.02 to $6.25 on revenue of $6.41 billion to $6.49 billion, up from its prior guidance for adjusted EPS of $5.89 to $6.11 on revenue of $6.38 billion to $6.47 billion.Analysts expect $6.00 and $6.42 billion, respectively.Also, the company said its board has approved an increase in the aggregate common stock repurchase authorization to $1 billion.Shares rose nearly 13% in Thursday afternoon trading.Price: $125.27, Change: $+14.37, Percent Change: +12.96%

$EHC
Wire

Encompass Health Raises Quarterly Dividend by $0.02 to $0.21 a Share; Payable Oct. 15 to Holders of Record Oct. 1

Encompass Health Raises Quarterly Dividend by $0.02 to $0.21 a Share; Payable Oct. 15 to Holders of Record Oct. 1

$EHC
Research

TD Cowen Initiates Encompass Health at Buy With $125 Price Target

Encompass Health (EHC) has an average rating of buy and mean price target of $140.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$EHC
Insider Trading

Encompass Health Insider Sold Shares Worth $2,958,550, According to a Recent SEC Filing

Douglas E Coltharp, Executive Vice President & Chief Financial Officer, on May 15, 2026, sold 27,694 shares in Encompass Health (EHC) for $2,958,550. Following the Form 4 filing with the SEC, Coltharp has control over a total of 260,237 common shares of the company, with 69,377 shares held directly and 190,860 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/785161/000078516126000158/xslF345X05/form4.xmlPrice: $106.89, Change: $+0.25, Percent Change: +0.23%

$EHC

Track with the FINWIRES app suite